Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Sage Therapeutics, Inc. SAGE

Full chart Compare
Set alert

Price alert · SAGE

All alert types
8.68 0.00 (+0.00%)

At closeJul 31, 2025, 4:00 PM EDT

8.68 Day range 8.68

52-week range unavailable

YTD
+59.85%
1 year
-19.63%

Revenue & Expenses

Other Income → Expenses: $31.70MExpenses → Selling, General & Admin: $216.42MExpenses → Research & Development: $225.90MExpenses → Other Operating Expenses: $21.85MGross Profit → Expenses: $31.80MRevenue → Gross Profit: $31.80MRevenue → Cost of Revenue: $9.44MNet Loss → Expenses: $400.67MOther Income$31.70MGross Profit$31.80MNet Loss$400.67MCost of Revenue$9.44MExpenses$464.17MSelling, General & Admin$216.42MResearch & Development$225.90MOther Operating Expenses$21.85MRevenue$41.24M

Latest period ending Dec 31, 2024 · select a line to chart its full history

Income statement

Full income statement How to read it
SAGE annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
41.24M86.45M7.69M6.31M1.11B
31.80M84.30M6.87M5.75M1.11B
-432.37M-579.85M-546.99M-460.91M596.23M
-400.67M-541.49M-532.78M-457.89M606.07M
-6.59-9.05-8.98-7.8011.43

Balance sheet

Full balance sheet How to read it
SAGE annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
82.47M72.32M163.97M295.50M1.66B
547.22M882.28M1.36B1.83B2.16B
82.13M82.75M103.85M96.26M86.91M
11.84M5.17M12.13M18.43M28.10M
465.09M799.53M1.25B1.73B2.07B

Cash flow

Full cash flow How to read it
SAGE annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-267.19M-540.59M-460.04M-378.18M664.28M
266.68M442.91M325.43M-1.00B442.68M
10.66M6.03M3.07M13.33M426.76M
10.15M-91.64M-131.53M-1.37B1.53B